查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654146

医药第三方物流市场规模、份额、趋势分析报告：按产品、温度、治疗领域、製造商规模、服务、地区、细分预测，2025-2030 年

Pharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report By Product, By Temperature, By Therapeutic Area, By Manufacturer Size, By Service, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

医药第三方物流市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，到2030年全球医药第三方物流市场规模预计将达到2,285.4亿美元，2025年至2030年期间的复合年增长率为8.95%。

由于生技药品和基因疗法等新治疗方法的出现，严格的监管环境和与药品分销相关的日益增加的挑战推动了这个市场的发展。这种复杂性需要许多製药公司内部缺乏的物流专业知识，促使他们将物流功能外包给第三方物流供应商，以便专注于研发等核心竞争力。

此外，温控物流需求的不断成长也是推动市场成长的因素之一。一些药物，特别是生技药品和疫苗，需要从生产到分销的整个供应链中进行温度控制。因此，需要专门的低温运输能力来确保这些温度敏感产品的完整性和效力。这些因素使得对拥有专业知识和基础设施以在整个分销过程中维持必要温度条件的第三方物流供应商的需求更大。

此外，技术进步也大大改变了医药物流格局。区块链、物联网 (IoT) 和人工智慧 (AI) 等最尖端科技的融合正在彻底改变供应链可视性、增强库存控制并实现对货物的即时追踪和监控。这些技术创新使第三方物流供应商能够优化物流业务、降低风险并及时有效地将药品送到患者手中。

医药第三方物流市场的主要企业正在策略性地投资扩大其全球影响力、加强其低温运输能力并整合先进技术，以保持竞争力并满足製药业不断变化的需求。全球医药供应链日益复杂以及温度敏感产品运输量的增加，促使第三方物流供应商加强低温运输物流基础设施。这些投资主要集中在建立最先进的设施，包括温控仓储和冷藏运输，以确保敏感医药产品的安全有效地运送。例如，DHL供应链于2024年2月宣布将投资2亿美元扩大其生命科学和医疗物流业务。此项投资将增强 DHL 处理温度敏感型医药产品的能力，并改善低温运输物流和合规性。

医药第三方物流市场报告重点

  • 就产品类型而言，由于配方的进步和创新治疗方法的增加，品牌药物在市场上占据主导地位。製药公司不断开发针对复杂疾病的标靶治疗，促进了该领域的发展。
  • 依温度划分，2024年常温占据最大的市场占有率。这是因为很多药物不需要温控环境来储存和运输。
  • 根据治疗领域，肿瘤学在 2024 年占据最大的市场占有率。由于全球癌症发病率不断上升以及对包括生物製药和标靶治疗在内的专门治疗的需求不断增长，该领域的市场预计将扩大。
  • 根据製造商规模，大型公司在 2024 年占据最大的市场占有率。这主要归功于我们拥有充足的财务资源来投资大规模的生产能力、广泛的分销网络和先进的物流解决方案。
  • 按服务划分，仓储和航运在 2024 年占据最大的市场占有率。这是因为迫切需要安全、可靠的储存和高效的运输药品，包括对温度敏感的药品。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场趋势与展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第 4 章。

  • 细分仪表板
  • 医药第三方物流(3PL) 服务市场：产品差异分析
  • 2018 年至 2030 年医药第三方物流(3PL) 服务规模及趋势分析（依产品）
  • 品牌
  • 非专利的
  • 生物相似药
  • 疫苗
  • 细胞疗法
  • 基因治疗
  • 其他的

第五章：医药第三方物流(3PL) 服务市场：温度估计与趋势分析

  • 细分仪表板
  • 医药第三者物流(3PL) 服务市场：温度波动分析
  • 2018 年至 2030 年按温度分類的医药第三方物流(3PL) 服务规模与趋势分析
  • 环境的
  • 冷藏
  • 冷冻
  • 超冷冻/冷冻
  • 低温

第六章 医药第三方物流(3PL) 服务市场：治疗领域估计与趋势分析

  • 细分仪表板
  • 医药第三方物流(3PL) 服务市场：治疗领域变化分析
  • 2018 年至 2030 年按治疗领域分類的医药第三方物流(3PL) 服务规模与趋势分析
  • 肿瘤学
  • 心血管疾病
  • 感染疾病
  • 神经病学
  • 糖尿病
  • 肾臟科
  • 风湿病学
  • 过敏/气喘
  • 胃肠病学
  • 眼科
  • 其他的

第七章 医药第三方物流(3PL) 服务市场：製造商规模估计与趋势分析

  • 细分仪表板
  • 医药第三方物流（3PL）服务市场：製造商规模变化分析
  • 2018 年至 2030 年医药第三方物流(3PL) 服务规模及趋势分析（依製造商规模）
  • 大的
  • 中等的
  • 小的

第 8 章：医药第三方物流(3PL) 服务市场：服务评估与趋势分析

  • 细分仪表板
  • 医药第三方物流(3PL) 服务市场：服务波动分析
  • 2018 年至 2030 年医药第三方物流(3PL) 服务规模与趋势分析（依服务划分）
  • 储存和运输
  • 从订单到现金
  • 标题 型号
  • DSCSA 和序列化服务
  • 药品样品
  • 其他的

第九章 区域经营分析

  • 区域控制面板
  • 2018 年至 2030 年市场规模、预测与趋势分析
  • 北美洲
    • 2018 年至 2030 年北美医药第三者物流市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018 年至 2030 年欧洲医药第三方物流市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018 年至 2030 年亚太地区医药第三方物流市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018 年至 2030 年拉丁美洲医药第三方物流市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018 年至 2030 年中东及非洲医药第三方物流市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 公司分类
  • 2024 年企业市场分析
  • 公司简介
    • CEVA Logistics
    • Cencora Corporation（ICS）
    • DB SCHENKER
    • Kuehne+Nagel
    • Kerry Logistics Network Limited
    • Cardinal Health
    • McKesson Corporation
    • EVERSANA.
    • Thermo Fisher Scientific Inc.
    • Knipper Health
Product Code: GVR-4-68040-495-4

Pharmaceutical Third-Party Logistics Market Growth & Trends:

The global pharmaceutical third-party logistics market is expected to reach USD 228.54 billion by 2030, expanding at a CAGR of 8.95% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven due to stringent regulatory landscapes, and the emergence of novel therapies like biologics and gene therapies which have increased the challenges associated with drug distribution. This complexity requires specialized logistics expertise that many pharmaceutical companies lack internally, encouraging them to outsource logistics functions to 3PL providers to concentrate on their core competencies, such as research and development.

Furthermore, growing demand for temperature-controlled logistics is also one of the factors driving market growth. Several pharmaceutical products, particularly biologics and vaccines, demand temperature control throughout the entire supply chain, from manufacturing to the point of delivery. Thus, to ensure the integrity and efficacy of these temperature-sensitive products necessitates specialized cold chain capabilities. These factors are further driving the demand for 3PL providers with the expertise and infrastructure to maintain the required temperature conditions throughout the entire distribution process.

In addition, technological advancements are also transforming the pharmaceutical logistics landscape. The integration of cutting-edge technologies such as blockchain, the Internet of Things (IoT), and artificial intelligence (AI) is revolutionizing supply chain visibility, enhancing inventory management, and enabling real-time tracking and monitoring of shipments. These technological innovations empower 3PL providers to optimize logistics operations, minimize risks, and ensure timely and efficient delivery of pharmaceuticals to patients.

Key players in the pharmaceutical 3PL market are strategically investing in expanding their global presence, enhancing their cold chain capabilities, and integrating advanced technologies to maintain a competitive edge and meet the evolving demands of the pharmaceutical industry. The increasing complexity of global pharmaceutical supply chains and the rise in the transportation of temperature-sensitive products, have prompted 3PL providers to strengthen their cold chain logistics infrastructure. These investments focus on establishing state-of-the-art facilities, such as temperature-controlled warehouses and refrigerated transport, to ensure the safe and effective delivery of sensitive drugs. For instance, in February 2024, DHL supply chain announced to invest USD 200 million which aims to expand life sciences and healthcare logistics operations. This investment will enhance DHL's capabilities in handling temperature-sensitive pharmaceutical products, improving cold chain logistics and compliance.

Pharmaceutical Third-Party Logistics Market Report Highlights:

  • Based on Product, branded dominated the market due to advancements in drug formulations and the increasing availability of innovative therapies. Pharmaceutical companies are constantly developing targeted treatments for complex diseases which are contributing to the segment growth.
  • Based on the temperature, ambient held the largest market share in 2024, as a wide range of pharmaceutical products do not require temperature-controlled environments for storage and transportation.
  • Based on the therapeutic area, oncology held the largest market share in 2024. The market for the segment is projected to expand due to the increasing prevalence of cancer worldwide and the growing demand for specialized treatments, including biologics and targeted therapies.
  • Based on the manufacturer size, large held the largest market share in 2024. This is primarily due to their extensive production capabilities, larger distribution networks, and greater financial resources to invest in advanced logistics solutions.
  • Based on the service, storage and shipping held the largest market share in 2024. This is due to the critical need for secure, reliable storage and efficient transportation of pharmaceutical products, including temperature-sensitive drugs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Temperature Segment
    • 1.2.3. Therapeutic Area Segment
    • 1.2.4. Manufacturer Size Segment
    • 1.2.5. Service Segment
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. The Rise of E-Commerce
      • 3.3.1.2. Growing Demand for Outsourcing Services
      • 3.3.1.3. Rising Demand for Cold Chain Logistics
      • 3.3.1.4. Growing Applications of Reverse Logistics in Biopharmaceutical Industry
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High Operational Costs
      • 3.3.2.2. Compliance Issues While Outsourcing
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
    • 3.4.2. PESTEL Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Third-Party Logistics (3PL) Services Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Product Movement Analysis
  • 4.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Branded
    • 4.4.1. Branded market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Generic
    • 4.5.1. Generic market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Biosimilar
    • 4.6.1. Biosimilar market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Vaccine
    • 4.7.1. Vaccine market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Cell Therapy
    • 4.8.1. Cell therapy market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Gene Therapy
    • 4.9.1. Gene therapy market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Pharmaceutical Third-Party Logistics (3PL) Services Market: Temperature Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Temperature Movement Analysis
  • 5.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Temperature, 2018 to 2030 (USD Million)
  • 5.4. Ambient
    • 5.4.1. Ambient market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Refrigerated
    • 5.5.1. Refrigerated market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Frozen
    • 5.6.1. Frozen market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Ultra-frozen/Deep-Frozen
    • 5.7.1. Ultra-frozen/Deep-Frozen market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Cryogenic
    • 5.8.1. Cryogenic market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Pharmaceutical Third-Party Logistics (3PL) Services Market: Therapeutic Area Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Therapeutic Area Movement Analysis
  • 6.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Cardiovascular Diseases
    • 6.5.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Infectious Diseases
    • 6.6.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Neurology
    • 6.7.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Diabetes
    • 6.8.1. Diabetes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Nephrology
    • 6.9.1. Nephrology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.10. Rheumatology
    • 6.10.1. Rheumatology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.11. Allergy/Asthma
    • 6.11.1. Allergy/Asthma market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.12. Gastroenterology
    • 6.12.1. Gastroenterology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.13. Ophthalmology
    • 6.13.1. Ophthalmology market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.14. Others
    • 6.14.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Pharmaceutical Third-Party Logistics (3PL) Services Market: Manufacturer Size Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Manufacturer Size Movement Analysis
  • 7.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Manufacturer Size, 2018 to 2030 (USD Million)
  • 7.4. Large
    • 7.4.1. Large market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Medium
    • 7.5.1. Medium market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Small
    • 7.6.1. Small market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Pharmaceutical Third-Party Logistics (3PL) Services Market: Service Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Pharmaceutical Third-Party Logistics (3PL) Services Market; Service Movement Analysis
  • 8.3. Pharmaceutical Third-Party Logistics (3PL) Services Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 8.4. Storage and Shipping
    • 8.4.1. Storage and Shipping market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Order-to-cash
    • 8.5.1. Order-to-cash market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Title Model
    • 8.6.1. Title Model market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. DSCSA and Serialization Services
    • 8.7.1. DSCSA and Serialization Services market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Pharmaceutical Sampling
    • 8.8.1. Pharmaceutical Sampling market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. Others
    • 8.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. Germany Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.3. UK
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. UK Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. South Korea Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.6. Australia
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. Australia Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.5.7. Thailand
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. Thailand Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait Pharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Company Market Position Analysis, 2024
  • 10.3. Company Profiles
    • 10.3.1. CEVA Logistics
      • 10.3.1.1. Company overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Service benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. Cencora Corporation (ICS)
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Service benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. DB SCHENKER
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Service benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. Kuehne+Nagel
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Service benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Kerry Logistics Network Limited
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Service benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Cardinal Health
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Service benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. McKesson Corporation
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Service benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. EVERSANA.
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Service benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Thermo Fisher Scientific Inc.
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Service benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Knipper Health
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Service benchmarking
      • 10.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 5 Global Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 6 Global Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 7 Global Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 8 Global Pharmaceutical Third-party Logistics (3PL) Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 12 North America Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 13 North America Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 14 North America Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 15 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 17 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 18 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 19 U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 20 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 22 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 23 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 24 Canada Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 25 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 27 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 28 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 29 Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 30 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 33 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 34 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 35 Europe Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 36 UK Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 37 UK Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 38 UK Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 39 UK Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 40 UK Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 41 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 43 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 44 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 45 Germany Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 46 France Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 France Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 48 France Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 49 France Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 50 France Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 51 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 53 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 54 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 55 Italy Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 56 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 58 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 59 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 60 Spain Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 61 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 63 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 64 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 65 Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 66 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 68 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 69 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 70 Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 71 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 73 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 74 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 75 Norway Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 81 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 82 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 83 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 84 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 85 Japan Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 86 China Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 87 China Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 88 China Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 89 China Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 90 China Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 91 India Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 92 India Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 93 India Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 94 India Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 95 India Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 96 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 98 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 99 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 100 Australia Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 101 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 102 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 103 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 104 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 105 South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 106 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 107 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 108 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 109 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 110 Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 111 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
  • Table 112 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 113 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 114 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 115 Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 116 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 117 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 118 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 119 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 120 Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 121 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 123 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 124 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 125 Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 126 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Country, 2018 - 2030 (USD Million)
  • Table 127 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 128 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 129 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 130 MEA Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 131 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 132 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 133 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 134 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 135 South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 137 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 141 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 142 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 143 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 144 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 145 UAE Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
  • Table 146 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Product, 2018 - 2030 (USD Million)
  • Table 147 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
  • Table 148 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Pharmaceutical Third-party Logistics (3PL) Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Pharmaceutical Third-party Logistics (3PL) Market: Product Key Takeaways
  • Fig. 14 Global Pharmaceutical Third-party Logistics (3PL) Market: Product Movement Analysis
  • Fig. 15 Global Pharmaceutical Third-party Logistics (3PL) Market, for Branded, 2018 - 2030 (USD Million)
  • Fig. 16 Global Pharmaceutical Third-party Logistics (3PL) Market, for Generic, 2018 - 2030 (USD Million)
  • Fig. 17 Global Pharmaceutical Third-party Logistics (3PL) Market, for Biosimilar, 2018 - 2030 (USD Million)
  • Fig. 18 Global Pharmaceutical Third-party Logistics (3PL) Market, for Vaccine, 2018 - 2030 (USD Million)
  • Fig. 19 Global Pharmaceutical Third-party Logistics (3PL) Market, for Cell Therapy, 2018 - 2030 (USD Million)
  • Fig. 20 Global Pharmaceutical Third-party Logistics (3PL) Market, for Gene Therapy, 2018 - 2030 (USD Million)
  • Fig. 21 Global Pharmaceutical Third-party Logistics (3PL) Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 22 Global Pharmaceutical Third-party Logistics (3PL) Market: Temperature Key Takeaways
  • Fig. 23 Global Pharmaceutical Third-party Logistics (3PL) Market: Temperature Movement Analysis
  • Fig. 24 Global Pharmaceutical Third-party Logistics (3PL) Market, for Ambient, 2018 - 2030 (USD Million)
  • Fig. 25 Global Pharmaceutical Third-party Logistics (3PL) Market, for Refrigerated, 2018 - 2030 (USD Million)
  • Fig. 26 Global Pharmaceutical Third-party Logistics (3PL) Market, for Frozen, 2018 - 2030 (USD Million)
  • Fig. 27 Global Pharmaceutical Third-party Logistics (3PL) Market, for Ultra-frozen/Deep-Frozen, 2018 - 2030 (USD Million)
  • Fig. 28 Global Pharmaceutical Third-party Logistics (3PL) Market, for Cryogenic, 2018 - 2030 (USD Million)
  • Fig. 29 Global Pharmaceutical Third-party Logistics (3PL) Market: Therapeutic Area Key Takeaways
  • Fig. 30 Global Pharmaceutical Third-party Logistics (3PL) Market, Therapeutic Area Movement Analysis
  • Fig. 31 Global Pharmaceutical Third-party Logistics (3PL) Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 32 Global Pharmaceutical Third-party Logistics (3PL) Market, for cardiovascular diseases, 2018 - 2030 (USD Million)
  • Fig. 33 Global Pharmaceutical Third-party Logistics (3PL) Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 34 Global Pharmaceutical Third-party Logistics (3PL) Market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 35 Global Pharmaceutical Third-party Logistics (3PL) Market, for Diabetes, 2018 - 2030 (USD Million)
  • Fig. 36 Global Pharmaceutical Third-party Logistics (3PL) Market, for Nephrology, 2018 - 2030 (USD Million)
  • Fig. 37 Global Pharmaceutical Third-party Logistics (3PL) Market, for Rheumatology, 2018 - 2030 (USD Million)
  • Fig. 38 Global Pharmaceutical Third-party Logistics (3PL) Market, for Allergy/Asthma, 2018 - 2030 (USD Million)
  • Fig. 39 Global Pharmaceutical Third-party Logistics (3PL) Market, for Gastroenterology, 2018 - 2030 (USD Million)
  • Fig. 40 Global Pharmaceutical Third-party Logistics (3PL) Market, for Ophthalmology, 2018 - 2030 (USD Million)
  • Fig. 41 Global Pharmaceutical Third-party Logistics (3PL) Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 42 Global Pharmaceutical Third-party Logistics (3PL) Market: Manufacturer Size Key Takeaways
  • Fig. 43 Global Pharmaceutical Third-party Logistics (3PL) Market, Manufacturer Size Movement Analysis
  • Fig. 44 Global Pharmaceutical Third-party Logistics (3PL) Market, for Large, 2018 - 2030 (USD Million)
  • Fig. 45 Global Pharmaceutical Third-party Logistics (3PL) Market, for Medium, 2018 - 2030 (USD Million)
  • Fig. 46 Global Pharmaceutical Third-party Logistics (3PL) Market, for Small, 2018 - 2030 (USD Million)
  • Fig. 47 Global Pharmaceutical Third-party Logistics (3PL) Market: Service Key Takeaways
  • Fig. 48 Global Pharmaceutical Third-party Logistics (3PL) Market, Service Movement Analysis
  • Fig. 49 Global Pharmaceutical Third-party Logistics (3PL) Market, for Storage and Shipping, 2018 - 2030 (USD Million)
  • Fig. 50 Global Pharmaceutical Third-party Logistics (3PL) Market, for Order-to-cash, 2018 - 2030 (USD Million)
  • Fig. 51 Global Pharmaceutical Third-party Logistics (3PL) Market, for Title Model, 2018 - 2030 (USD Million)
  • Fig. 52 Global Pharmaceutical Third-party Logistics (3PL) Market, for DSCSA and Serialization Services, 2018 - 2030 (USD Million)
  • Fig. 53 Global Pharmaceutical Third-party Logistics (3PL) Market, for Pharmaceutical Sampling, 2018 - 2030 (USD Million)
  • Fig. 54 Global Pharmaceutical Third-party Logistics (3PL) Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 55 Regional Marketplace: Key Takeaways
  • Fig. 56 Regional Outlook, 2024 & 2030
  • Fig. 57 North America Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 58 Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 59 Canada Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 61 Europe Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 62 Germany Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 63 UK Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 64 France Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 65 Italy Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 66 Spain Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 67 Denmark Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 68 Sweden Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 69 Norway Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 70 Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 71 Japan Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 72 China Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 73 India Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 74 Australia Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 75 South Korea Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 76 Thailand Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 77 Latin America Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 79 Argentina Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 80 Middle East and Africa Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 81 South Africa Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 83 UAE Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)
  • Fig. 84 Kuwait Pharmaceutical Third-party Logistics (3PL) Market, 2018 - 2030 (USD Million)